Doni Bloomfield

September 23, 2015

Big pharma lobby group forswears drugmaker targeted by Clinton

September 23, 2015

Big pharma lobby group forswears drugmaker targeted by Clinton

August 31, 2015

Alnylam’s new drug may prove threat to Sanofi, Regeneron, Amgen

July 24, 2015

Biogen slumps as forecast cut on multiple sclerosis competition

July 22, 2015

Biogen data complicates quest to slow Alzheimer’s disease

July 22, 2015

Biogen data complicates quest to slow Alzheimer’s disease

July 13, 2015

Gilead pills priced at $1,000 a day are found cost-effective

June 03, 2015

Deadly infections drive billions in hospital bills to Medicare

May 21, 2015

New York Life names Blunt to lead $540B investments group